Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
OneCell Diagnostics Inc. | $16,000,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
HEMEX
Switzerland
- Liestal, Schweiz
- 17/11/2022
- Series A
- $5,000,000
As a swiss investment and consulting company headquartered close to the Basel global life sciences hub, our main focus is to bring innovative drugs, medical devices and in vitro diagnostics to the market.
We specialize in supporting healthcare startups. Working closely with a management team, we offer tailored solutions to accelerate innovations into a successful and sustainable business.
Our team of life sciences, legal and financial professionals covers a wide range of expertise. From development support, including preclinical/clinical trial management, regulatory affairs, quality assurance, CMC and medical affairs, to business coaching, marketing strategy, intellectual property and finding financing solutions, we know how to successfully bring a product from the lab to the market.
Our offices in Switzerland, Germany and USA work closely with local health authorities, patient groups, contract research organizations and key opinion leaders.
- Industry Pharmaceutical Manufacturing
- Website https://hemex.ch/
- LinkedIn https://www.linkedin.com/company/hemex-ag/
Related People
Pascal WinnenFounder
Switzerland -
Liestal, Basel-Country
I co-founded HEMEX with the goal of changing the future of healthcare by guiding the most promising European start-ups through each and every step to bring innovative pharmaceuticals, medical devices and in vitro diagnostics to the market. Headquartered close to the thriving Basel global Life Sciences hub, the goal at HEMEX is to ensure start-ups have access to a wide range of tailored products, practical solutions and fundraising support, either in-house or via our network of pre-qualified experts, laboratories, CMOs, warehouses, logistic partners and affiliates. This empowers the next generation of transformative discoveries to grow into successful and sustainable businesses, and drive change in both human and animal healthcare.
Enveda | $130,000,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
DANNCE.ai | $2,600,000 | (Nov 22, 2024)
Trustero | $10,000,000 | (Nov 22, 2024)
Dote | $1,447,585 | (Nov 22, 2024)
CredFlow | $3,700,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
Faircraft | $15,800,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)